Consumer watchdog the Competition and Markets Authority (CMA) has provisionally found that drug company Concordia abused its dominant position to overcharge the NHS by millions for an essential thyroid drug.
In an investigation into pricing, the CMA found the NHS spent more than £34 million (US$45 million) last year on liothyronine tablets, an increase from around £600,000 (US$794,562) in 2006. The amount Concordia charged per pack rose from around £4.45 (US$5.89) before it was de-branded in 2007, to £258.19 (US$341.89) in July this year. This increase of almost 6,000% came despite the fact that production costs remained “broadly stable,” the CMA found.
“Pharmaceutical companies which abuse their position and overcharge for drugs are forcing the NHS — and the UK taxpayer — to pay over the odds for important medical treatments,” said Andrea Coscelli, CMA chief executive.
“We allege that Concordia used its market dominance in the supply of liothyronine tablets to do exactly that,” he said.
The CMA’s findings are provisional, pending further investigation, and the watchdog has not yet ruled Concordia breached competition law.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
FCC Votes to Restore Net Neutrality Rules
Apr 25, 2024 by
nhoch@pymnts.com
Apple Rejects Spotify’s Updated App Over In-App Pricing Disclosure
Apr 25, 2024 by
CPI
FCC Set to Reinstate Net Neutrality Rules Today
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI